Eli Lilly Joins Chase for Hot Inflammation Target, Paying $100M for Rights to CSL Drug
Eli Lilly has been scouting for medication to comply with the path blazed by its blockbuster cardiometabolic medicines. Its newest ...
Eli Lilly has been scouting for medication to comply with the path blazed by its blockbuster cardiometabolic medicines. Its newest ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Eli Lilly is building its prospects in immunology through the $1.2 billion acquisition of Ventyx Biosciences, a clinical-stage company with ...
WASHINGTON — The Food and Drug Administration on Thursday announced the second batch of companies being granted a “Commissioner’s National Priority ...
A good Thursday to you all, with Andrew Joseph here in London filling in for Mr. Pharmalot. A busy August ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Eli Lilly is expanding its pain drug pipeline with the acquisition of SiteOne Therapeutics, a startup whose lead program addresses ...
Amyotrophic lateral sclerosis has been a tough area for drug research, but Eli Lilly has been spreading its bets in ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.